Animal models of psoriasis - what can we learn from them?
about
Gene from a psoriasis susceptibility locus primes the skin for inflammationProteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu modelEfomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation.Psoriasis: the future.A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analoguesPsoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.Animal models of psoriasis and pustular psoriasis.SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitorIn vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery.Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.Review paper: preclinical models of psoriasis.Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.Preclinical and human surrogate models of itch.Antipsoriatic activity of extracts and fractions obtained from Memecylon malabaricum leaves.Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationToll-like receptors: role in dermatological disease.Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis.Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients.Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice.In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining.Sampling of disease biomarkers from skin for theranostic applications.A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.Humanised mouse models in drug discovery for skin inflammation.Aldara®-induced skin inflammation: studies of patients with psoriasis.Vitamin D3 derivatives, alone or in combination with glucocorticoids, suppress streptococcal pyrogenic enterotoxin A-stimulated proliferation of peripheral blood mononuclear cells in patients with psoriasis.The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis
P2860
Q24314913-7D5ECE63-FDA1-4E24-885D-11A676B0D61EQ24551280-DD3E22B3-79A2-4FCB-B4BC-F841967CC8F4Q30684054-1B0FC7B1-CBBA-4352-A762-99DBD31050EEQ31001401-DFF9C659-11FF-45CC-9070-556E0D66FE9FQ33865243-85617C79-2777-4C9D-95FB-1EA5C4232307Q34451039-2AC56772-9DC8-405D-9D84-BA34D8890587Q35083718-7E60446B-BAFA-4553-8028-5A6231E20C2EQ35099793-36552269-A802-43FA-81F7-38F03DAC6600Q35154156-E0FE90B6-AF0C-49DC-A2F8-6227264D13F2Q35945026-76CE9151-FCD0-45A1-9C16-9E2A143ABB5AQ36570707-D0C5861C-7FC0-4375-A688-4F9058EC51BCQ37154170-DA2C5A99-473C-4FD4-B12E-4A7B436770F6Q37202513-92754C36-C34B-4844-8A4A-B707516EA00DQ37617085-95B7C112-9711-479B-A084-93C537F4142DQ38834387-9982A0E7-B4E6-46A9-A9A4-EFCE48ECE126Q38837892-6387C2AA-15DA-4DFF-B211-FE853C919232Q39286365-CA1FF03D-E03F-40FB-AD9C-6A19BECD8A76Q39768274-02DB5129-2A21-40DC-BCB7-FAAA35539BBBQ40156550-A48A5C28-956C-4768-A274-5F93784A225EQ42415954-E68C7D68-9A90-438C-83D9-310A66B39651Q42431181-BAE6E0E0-F45A-4E6E-B0B2-335770212A5FQ42462805-A0C47D2E-5E90-40DE-A12A-A658D9C2B1EEQ44533419-EB6F98AF-593B-4ED4-BF95-586B4BB426B9Q44929215-59FA2048-BCDC-463A-BEB9-BFEC0D2F7906Q45812015-5D96D594-7AAF-4F26-9EA4-FEE156E159E4Q46490983-5344B216-91C3-4C7E-8C1A-707F5725382BQ46753306-F05DC37D-4E98-461C-A613-5CDE6AD9D94FQ52932628-F98A80AF-B741-4951-A71C-46863CC5712AQ54200281-4292BAE7-FF35-4ADB-B433-4F872FB869E0Q54279129-D9905AA2-6960-4893-A197-CE49537035DBQ59138381-1F724062-30E0-4F4B-A598-7ADBBB3B8350
P2860
Animal models of psoriasis - what can we learn from them?
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Animal models of psoriasis - what can we learn from them?
@ast
Animal models of psoriasis - what can we learn from them?
@en
type
label
Animal models of psoriasis - what can we learn from them?
@ast
Animal models of psoriasis - what can we learn from them?
@en
prefLabel
Animal models of psoriasis - what can we learn from them?
@ast
Animal models of psoriasis - what can we learn from them?
@en
P1476
Animal models of psoriasis - what can we learn from them?
@en
P2093
P304
P356
10.1046/J.1523-1747.1999.00538.X
P407
P577
1999-04-01T00:00:00Z
P6179
1053102833